Mesoblastic nephroma future or investigational therapies

Revision as of 19:35, 2 November 2015 by Shanshan Cen (talk | contribs) (Created page with "__NOTOC__ {{Mesoblastic nephroma}} {{CMG}}; {{AE}} {{SC}} ==Overview== ==References== {{reflist|2}} {{WH}} {{WS}} Category:Disease Category:Types of cancer")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Mesoblastic nephroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mesoblastic nephroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mesoblastic nephroma future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mesoblastic nephroma future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mesoblastic nephroma future or investigational therapies

CDC on Mesoblastic nephroma future or investigational therapies

Mesoblastic nephroma future or investigational therapies in the news

Blogs on Mesoblastic nephroma future or investigational therapies

Directions to Hospitals Treating Mesoblastic nephroma

Risk calculators and risk factors for Mesoblastic nephroma future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

References

Template:WH Template:WS